ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: NIH gives Advisors $50 Raise, Effective April 1, No Fooling

March 12, 1999

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

November 14, 2003

Cervical Screening Should Emphasize Older Women, ASP Members Told

March 14, 1986

Cooperation Is ACS Theme For ‘90s; Dodd

February 1, 1991

White House Appoints Slamon To Cancer Panel; Brinker To Address Republican Convention.

July 28, 2000

ASCO Weighs In On Tobacco Debate

September 19, 1997